Home / Erectile Dysfunction / New ED Drug Progresses to Market, May Provide Less Side Effects

New ED Drug Progresses to Market, May Provide Less Side Effects

It may take a few more years, but men may eventually have another FDA-approved alternative when it comes to providing effective treatment for erectile dysfunction (ED).

Pharmaceutical manufacturer Rexahn says their medication Zoraxel does not cause severe, rare side effects associated with Viagra/Cialis/Levitra. Zoraxel also stimulates neurotransmitters in the brain, whereas PDE-5 inhibitors only target end-organ erectile function and work in peripheral blood vessels.

Buy Legal FDA-approved prescription medications like Viagra, Cialis, Levitra and Staxyn From AccessRx Buy Legal FDA-approved prescription medications like Viagra, Cialis, Levitra and Staxyn From AccessRx

Rexahn announced earlier this week that it has completed enrollment in its Phase IIa clinical trial evaluating Zoraxel. A drug may be introduced to the FDA for approval after successful Phase 3 testing. Potential introduction to the U.S. market, then, could reasonably be expected in a few years, just about the time the patent for Viagra will expire (March, 2012).

Read the Rexahn press release from earlier this week regarding Zoraxel.

About AccessRX Staff

avatar
AccessRx is a USA corporation founded in 1998. Since, we have become one of the top online providers in FDA-approved, brand-name medications. We specializes in providing our over 500,000 customers with relevant product and condition information created by our professional editorial staff which includes our team of medical writers, medical practitioners and health educators. AccessRx Staff on Facebook

Comments are closed.

Scroll To Top